Cintas Corporation (CTAS) Stock Analysis

60.0/100
Hold ✓ Halal Industrials
Price $226.24
Market Cap $89.83B
52-Week Change +20.40%

Is CTAS a good investment?

Cintas Corporation (CTAS) has a Plutrex AI rating of 60.0/100 as of November 12, 2026, indicating a Hold consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Elite profitability moat: ROE of 41.2% is 130% above industry average (17.9%), gross margin of 49.3% is 55% above peers (31.8%), operating margin of 23.6% is 42% above industry (16.6%) — these margins reflect durable competitive advantages from route density, switching costs, and cross-selling that peers cannot easily replicate. Main concern: Valuation has WORSENED materially in 14 days: P/E expanded from 41.95x to 44.8x (+6.8%), PEG deteriorated from 3.56x to 3.80x (+6.8%), analyst target barely moved ($231.00 → $231.33, +0.1%), compressing potential upside from 8.5% to just 1.8% — the stock is now 26% above the upper bound of the defensible entry zone ($180), and paying 44.8x earnings for 11.4% forward EPS growth is mathematically indefensible at current price.

Investment Summary

Cintas (CTAS) at $227.26 is an exceptional business trapped in an overvalued stock. The fundamentals are genuinely elite: ROE of 41.2% (vs. industry average 17.9%), gross margin of 49.3% (vs. industry 31.8%), operating margin of 23.6% (vs. industry 16.6%), and $2.03B in annual free cash flow. Debt-to-equity of 0.32 is 56% below the industry average of 0.73. These are best-in-class metrics that justify a significant quality premium. However, the valuation is the problem: P/E of 44.8x for a business growing EPS at only 11.4% next year yields a PEG of 3.80 — nearly 4x the fair-value threshold of 1.0 and 21.8% above the already-elevated industry average PEG of 3.12. The analyst consensus target of $231.33 implies just 1.8% upside from current price — essentially no return on investment even if everything goes right. Since the prior report 14 days ago, the stock has risen +6.8% ($212.81 → $227.26), P/E has expanded from 41.95x to 44.8x, PEG has deteriorated from 3.56x to 3.80x, while the analyst target moved a mere +$0.33. The stock is now further from fair value than ever. News is positive (93.5/100) but entirely consistent with what's priced in — dividend continuity, Dividend Aristocrat rankings, and 'boring but resilient' narratives add no incremental fundamental catalyst. CTAS is a wonderful company at an increasingly uncompelling price.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
68/100
Growth Potential
37/100
Valuation
10/100
Profitability
92/100
Debt Management
72/100
Analyst Sentiment
65/100
Technical Momentum
60/100
Insider Confidence
62/100
News Sentiment
90/100

Fundamental Analysis

CTAS's fundamentals remain best-in-class across profitability and financial health, but valuation continues to deteriorate. Profitability: ROE of 41.2% is 130% above the industry average of 17.9%, gross margin of 49.3% is 55% above peers at 31.8%, operating margin of 23.6% is 42% above the industry's 16.6%, and net margin of 17.8% is 69% above peers at 10.5%. These metrics reflect a structurally superior business with route density moats, pricing power, and a recurring revenue model. Financial health: D/E of 0.32 (vs. industry 0.73) is conservative and a genuine strength; FCF of $2.03B annually is extraordinary and dwarfs the modest cash balance of $364.6M on the balance sheet. Growth: Next-year EPS growth of 11.4% and 5-year EPS CAGR of 11.8% are consistent and predictable but below the industry average next-year EPS growth of 14.87% — a critical gap. Revenue growth of 10.9% leads peers (vs. 8.04% industry), but EPS growth lags. Valuation: P/E of 44.8x vs. industry 29.1x (54% premium); PEG of 3.80x vs. industry 3.12x (22% premium); P/B of 17.45x vs. a DCF-justified fair value of $130-$150. The analyst consensus target of $231.33 offers only 1.8% upside — insufficient for any risk-adjusted return calculation. The core problem: investors are paying 44.8x earnings for 11-12% growth, which requires either a massive re-rating of growth expectations or a painful multiple compression.

News Sentiment

Cintas Corporation continues to earn its reputation as one of the most reliable — if unexciting — companies in the American business landscape, according to recent coverage. Multiple outlets have highlighted Cintas as a prime example of a 'boring' stock that quietly delivers for long-term investors, with one piece titled 'The Beauty Behind Boring Stocks During Market Volatility' specifically calling out the company's resilience across economic cycles. That defensive reputation is backed by action: Cintas recently announced its latest quarterly cash dividend, reinforcing its position as a certified Dividend Aristocrat — a club of companies that have raised dividends consistently for 25+ years. A November 2026 ranking of '69 Dividend Champions Ranked By Quality Scores' placed Cintas among the elite, with Dividend Aristocrats collectively averaging a 4.55% dividend increase in 2026, supported by double-digit hikes from leading names. Meanwhile, an article comparing Cintas to Rollins — which 'Has Grown Revenue for 100 Straight Quarters' — painted a picture of a company with an almost mechanical ability to keep customers coming back, quarter after quarter. The reincorporation from Washington state to Delaware, approved by shareholders at the 2026 annual meeting, adds a layer of corporate governance modernization. For everyday investors, the message is clear: Cintas is a company that pays you to wait, keeps customers loyal through long-term service contracts, and rarely makes headlines for the wrong reasons. The only catch? The stock price already reflects all of this.

Risk Assessment

PRIMARY RISK: Multiple compression. At P/E of 44.8x with only 11.4% forward EPS growth, any re-rating toward even a modest 35x (still a significant premium) would imply a stock price around $177 — a 22% drawdown from current levels. SECONDARY RISK: Macro sensitivity. While CTAS is often cited as 'defensive' (see news headline: 'The Beauty Behind Boring Stocks During Market Volatility'), uniform and facility services revenue is exposed to employment levels. A recession-driven headcount reduction at corporate clients would slow growth below the already-modest 11.4% EPS target. TERTIARY RISK: Analyst target convergence. Consensus target of $231.33 (just 1.8% above current price) means sell-side is essentially at a hold — any negative earnings guidance revision or macro deterioration could quickly put the stock above target, triggering downgrades. MITIGATION: For current holders, the $2.03B FCF, Dividend Aristocrat status, and durable moat justify holding through volatility. For new buyers, the risk/reward does not justify entry at $227.26 when the entry zone of $165-$180 offers a 3.4x risk/reward ratio to the analyst target, vs. a negative expected return at current price.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is CTAS a halal stock?

Yes, Cintas Corporation (CTAS) is halal-compliant per AAOIFI standards as of the latest quarterly review.

What is Plutrex's AI rating for CTAS?

Cintas Corporation (CTAS) has a Plutrex AI rating of 60.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is CTAS a good investment?

According to Plutrex AI, CTAS has a Hold rating (60.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in CTAS?

US stocks like CTAS can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in CTAS?

Plutrex AI identifies the main risks for CTAS by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about CTAS

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open CTAS in ElBarake